BSE, Bata, Aurobindo Pharma and 9 Other Stocks Announcing Q3 Results Today

BSE, Bata, Aurobindo Pharma and 9 Other Stocks Announcing Q3 Results Today

Synopsis: Companies across sectors such as financial services, pharmaceuticals, chemicals, consumer durables, cement,,, and infrastructure, including Cholamandalam Financial Holdings, Amber Enterprises, Lloyds Enterprises, Man Industries, are all scheduled to announce their Q3 results today.

On Friday, the Nifty 50 ended higher at 25,693  versus its previous close of 25,642, while the Sensex rose to 83,580 from 83,313. The stocks across diverse sectors, including financial services, pharmaceuticals, speciality chemicals, consumer durables, cement, fertilisers, hospitality, and infrastructure, are set to announce their Q3 results today.

BSE Limited

BSE Limited, incorporated in 1875 and headquartered in Mumbai, is Asia’s oldest stock exchange. It provides trading, clearing, settlement, depository, and market data services, serving investors, brokers, corporates, and institutions across multiple asset classes.

With a market capitalisation of more than Rs. 1.1 lakh cr, the shares of BSE Limited closed at Rs. 2885 per share, down by less than a percent from its previous close of Rs. 2892 per share. Sales increased from Rs. 958 cr in Q1FY26 to Rs. 1,068 cr in Q2FY26. Operating profit rose from Rs. 625 cr to Rs. 680 cr. Net profit also rose from Rs. 538  cr to Rs. 557 cr.

Zydus Lifesciences Ltd.

Zydus Lifesciences, incorporated in 1995 and headquartered in Ahmedabad, is a global pharmaceutical company engaged in manufacturing formulations, APIs, vaccines, and biologics, with a strong presence across regulated and emerging healthcare markets.

With a market capitalisation of Rs. 89,000cr, the shares of Zydus Lifesciences closed at Rs. 887 per share, down by 2 percent from its previous close of Rs. 905 per share. Sales increased from Rs. 6,574 cr in Q1FY26 to Rs. 6,123 cr in Q2FY26. Operating profit fell from Rs. 2,088 cr to Rs. 2,016cr. Net profit also fell from Rs. 1,521 cr to Rs. 1,239 cr.

Navin Fluorine International

Navin Fluorine International, incorporated in 1967 and headquartered in Mumbai, is a specialty fluorochemicals company catering to pharmaceuticals, agrochemicals, refrigerants, and specialty chemicals, serving global customers through advanced manufacturing and innovation capabilities.

With a market capitalisation of more than Rs. 32,800 cr, the shares of Navin Fluorine International closed at Rs. 6,418 per share, up by 2 percent from its previous close of Rs. 6282 per share. Sales increased from Rs. 725 cr in Q1FY26 to Rs. 758 cr in Q2FY26. Operating profit rose from Rs. 207 cr to Rs. 246 cr. Net profit also rose from Rs. 117 cr to Rs. 148 cr.

Cholamandalam Financial Holdings

Cholamandalam Financial Holdings, incorporated in 1949 and headquartered in Chennai, is a Murugappa Group company engaged in financial services through subsidiaries offering vehicle finance, home loans, insurance, and asset management solutions across India.

With a market capitalisation of Rs. 31,000 cr, the shares of Cholamandalam Financial Holdings closed at Rs. 1651 per share, down by 1 percent from its previous close of Rs. 1674 per share. Sales increased from Rs. 9,296 cr in Q1FY26 to Rs. 9,461 cr in Q2FY26. Operating profit fell from Rs. 5,154 cr to Rs. 5,102 cr. Net profit also fell from Rs. 1,260 cr to Rs. 1,214 cr.

Amber Enterprises India Limited

Amber Enterprises India, incorporated in 1990 and headquartered in Gurugram, is a leading contract manufacturer of air conditioners and consumer durables, serving major domestic and global brands with end-to-end design and manufacturing solutions.

With a market capitalisation of more than Rs. 23,300cr, the shares of Amber Enterprises India Limited closed at Rs. 6,641 per share, up by 4 percent from its previous close of Rs. 6,400 per share. Sales decreased from Rs. 3,449 cr in Q1FY26 to Rs. 1,647 cr in Q2FY26. Operating profit fell from Rs. 250 cr to Rs. 84 cr. Net profit of Rs 106 Cr in Q1FY26 turned to loss of Rs. 32 cr.

Lloyds Enterprises

Lloyds Enterprises, incorporated in 1986 and headquartered in Mumbai, operates across engineering, infrastructure, and manufacturing segments, offering specialized solutions in heavy engineering, fabrication, and industrial project execution for domestic and international clients.

With a market capitalisation of Rs. 7,600 cr, the shares of Lloyds Enterprises closed at Rs. 60 per share, down by 3 percent from its previous close of Rs. 62 per share. Sales increased from Rs. 331 cr in Q1FY26 to Rs. 407 cr in Q2FY26. Operating profit rose from Rs. 22 cr to Rs. 24 cr. While the Net profit fell from Rs. 249 cr to Rs. 62 cr.

Man Industries (India)

Man Industries (India), incorporated in 1988 and headquartered in Mumbai, is a leading manufacturer of large-diameter carbon steel pipes for oil, gas, water, and infrastructure projects across domestic and international markets.

With a market capitalisation of more than Rs. 2,700 cr, the shares of Man Industries (India) closed at Rs. 363 per share, up by 4 percent from its previous close of Rs. 348 per share. Sales increased from Rs. 742 cr in Q1FY26 to Rs. 834 cr in Q2FY26. Operating profit rose from Rs. 49 cr to Rs. 121 cr. Net profit also rose from Rs. 28 cr to Rs. 37 cr.

Bata India

Bata India, incorporated in 1931 and headquartered in Gurugram, is a leading footwear manufacturer and retailer, offering shoes, accessories, and apparel through a wide network of retail stores, e-commerce platforms, and distributors across India.

With a market capitalisation of more than Rs. 10,800 Cr, the shares of Bata India closed at Rs. 848 per share, down by less than a percent from its previous close of Rs. 851 per share. Sales decreased from Rs. 942 cr in Q1FY26 to Rs. 801 cr in Q2FY26. Operating profit fell from Rs. 199 cr to Rs. 145 cr. Net profit also fell from Rs. 52 cr to Rs. 14 cr.

The Ramco Cements

The Ramco Cements, incorporated in 1957 and headquartered in Chennai, is a leading cement manufacturer with strong presence in South India, producing cement, clinker, and dry mortar products for infrastructure and housing projects.

With a market capitalisation of Rs. 27,300 cr, the shares of The Ramco Cements closed at Rs. 1160.2 per share, down by less than a percent from its previous close of Rs. 1160.9 per share. Sales increased from Rs. 2,074 cr in Q1FY26 to Rs. 2,239 cr in Q2FY26. Operating profit fell from Rs. 398 cr to Rs. 388 cr. Net profit also fell from Rs. 85 cr to Rs. 78 cr.

Gujarat State Fertilisers & Chemicals

Gujarat State Fertilisers & Chemicals, incorporated in 1962 and headquartered in Vadodara, is a leading fertilizer and chemical manufacturer producing fertilizers, polymers, fibres, and industrial chemicals for agricultural and industrial applications.

With a market capitalisation of Rs. 7,000 cr, the shares of Gujarat State Fertilizers & Chemicals closed at Rs. 177 per share, down by less than a percent from its previous close of Rs. 178 per share. Sales increased from Rs. 2,184 cr in Q1FY26 to Rs. 3,187 cr in Q2FY26. Operating profit rose from Rs. 193 cr to Rs. 338 cr. Net profit also rose from Rs. 139 cr to Rs. 324 cr.

Taj GVK Hotels & Resorts

Taj GVK Hotels & Resorts, incorporated in 1981 and headquartered in Hyderabad, operates luxury hotels and resorts in partnership with Indian Hotels Company, offering premium hospitality services across major business and leisure destinations in India.

With a market capitalisation of Rs. 2,200 cr, the shares of Taj GVK Hotels & Resorts closed at Rs. 359 per share, down by 3 percent from its previous close of Rs. 369 per share. Sales increased from Rs. 106 cr in Q1FY26 to Rs. 107 cr in Q2FY26. Operating profit rose from Rs. 32 cr to Rs. 34 cr. Net profit fell from Rs. 36 cr to Rs. 24 cr.

Aurobindo Pharma

Aurobindo Pharma, incorporated in 1986 and headquartered in Hyderabad, is a global pharmaceutical company engaged in manufacturing generic medicines, APIs, injectables, and speciality products, supplying to regulated and emerging healthcare markets worldwide.

With a market capitalisation of Rs. 69,300 cr, the shares of Aurobindo Pharma closed at Rs. 1191 per share, up by almost 1 percent from its previous close of Rs. 1182 per share. Sales increased from Rs. 7,868 cr in Q1FY26 to Rs. 8,286 cr in Q2FY26. Operating profit rose from Rs. 1,603 cr to Rs. 1,678 cr. Net profit also rose from Rs. 824 cr to Rs. 848 cr.

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

  • Aditya Menon has cleared the CFA Level I and has over 3+ years of experience in equity analysis, investing, and sectoral research. He actively tracks financial markets to deliver clear, investor-friendly content, and has also covered real estate markets and personal finance topics in the past.

    Financial Analyst

Leave a Reply

Your email address will not be published. Required fields are marked *